biopharma supply chain
Dr. Rafik Bishara on the New Risk Management PDA Technical Document and Risk in Today’s Biopharma Supply Chain
March 14 by Pharmaceuticals & Biotechnology EditorGeoffrey Glauser, Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health & Human Services (HHS), interviews Dr. Rafik Bishara PhD, Technical Advisor ...
Dr. Rafik Bishara on the New Risk Management PDA Technical Document and Risk in Today’s Biopharma Supply Chain
March 14 by Pharmaceuticals & Biotechnology EditorGeoffrey Glauser, Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health & Human Services (HHS), interviews Dr. Rafik Bishara PhD, Technical Advisor ...
